MQQQ yields 2.33% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 8
Combined, MQQQ + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MQQQ + JNJ for your $10,000?
MQQQ provides 2x leveraged exposure to the monthly performance of QQQ, an ETF composed of 100 NASADAQ-listed stocks. The strategy involves entering into one or more swap agreements intended to produce leveraged investment results relative to the returns of QQQ. Unlike traditional ETFs, MQQQ introduces added volatility due to its lack of diversification and use of leverage. Holdings are rebalanced at month-end to maintain the 200% exposure. However, if QQQs price drops by 35% or more within a month, the fund will rebalance early to protect against further losses, although this may prevent it from meeting its target return for that month. To maximize results, the fund places its remaining cash in US government securities, money market funds, short-term bond ETFs, or high-quality corporate debt as collateral. Before May 16, 2025, the fund was named Tradr 2X Long Triple Q Monthly ETF.
Full MQQQ Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.